Zhende Medical(SH:603301) Chang Jiang Shang Bao·2025-09-14 23:19Core Viewpoint - The stock price of Zhendemedical (603301.SH) has surged, achieving three limit-up days in four trading sessions, primarily due to the strategic investment by steel magnate Sun Jimu [2][3]. Group 1: Stock Performance - Zhendemedical's stock price opened high and reached the limit-up within four minutes on September 12, marking its third limit-up in four trading days [2]. - The stock price was transferred at 26.74 CNY per share, approximately 10% lower than the previous closing price of 29.71 CNY [3]. Group 2: Share Transfer Details - The controlling shareholder, Zhejiang Zhendemedical Holdings Co., Ltd., and its subsidiary plan to transfer a total of 5% of the company's shares to Sun Jimu for a total consideration of 356 million CNY [3]. - The share transfer includes 1,332,600 shares, with Zhejiang Zhendemedical transferring 154,860 shares and its subsidiary transferring 1,177,390 shares [3][4]. Group 3: Company Background - Zhendemedical specializes in the production, research, and sales of medical dressings, with products distributed in over 70 countries and regions, generating approximately 60% of its revenue from overseas markets [3][8]. - The company has established a strong market presence, covering over 9,200 hospitals in China, including more than 1,200 top-tier hospitals [8][9]. Group 4: Financial Performance - Zhendemedical's net profit has shown volatility, with figures of 596 million CNY, 681 million CNY, 198 million CNY, and 385 million CNY from 2021 to 2024, and a net profit of 128 million CNY in the first half of 2025 [9][10]. - The company has consistently paid dividends since its listing in 2018, distributing a total of 1.46 billion CNY in cash dividends with an average payout ratio of 30.26% [11].